-
1دورية أكاديمية
المؤلفون: Rautman LH; Emory University Rollins School of Public Health, Atlanta, GA., Kammerer JS; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA., Silk BJ; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA., Marconi VC; Emory University Rollins School of Public Health, Atlanta, GA, Emory University School of Medicine, Atlanta, GA, USA., Youngblood ME; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA., Edwards JA; Emory University Rollins School of Public Health, Atlanta, GA., Wortham JM; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA., Self JL; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, GA.
المصدر: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2024 May 01; Vol. 28 (5), pp. 231-236.
نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.
بيانات الدورية: Publisher: The Union Country of Publication: France NLM ID: 9706389 Publication Model: Print Cited Medium: Internet ISSN: 1815-7920 (Electronic) Linking ISSN: 10273719 NLM ISO Abbreviation: Int J Tuberc Lung Dis Subsets: MEDLINE
مواضيع طبية MeSH: Sputum*/microbiology , Tuberculosis, Pulmonary*/diagnosis , Tuberculosis, Pulmonary*/epidemiology , Tuberculosis, Pulmonary*/microbiology, Humans ; United States ; Adolescent ; Male ; Middle Aged ; Adult ; Young Adult ; Female ; Aged ; Child ; Child, Preschool ; Infant ; Logistic Models ; Mycobacterium tuberculosis/isolation & purification
-
2دورية أكاديمية
المؤلفون: Wortham JM, Haddad MB, Stewart RJ, Annambhotla P, Basavaraju SV, Nabity SA, Griffin IS, McDonald E, Beshearse EM, Grossman MK, Schildknecht KR, Calvet HM, Keh CE, Percak JM, Coloma M, Shaw T, Davidson PJ, Smith SR, Dickson RP, Kaul DR, Gonzalez AR, Rai S, Rodriguez G, Morris S, Armitige LY, Stapleton J, Lacassagne M, Young LR, Ariail K, Behm H, Jordan HT, Spencer M, Nilsen DM, Denison BM, Burgos M, Leonard JM, Cortes E, Thacker TC, Lehman KA, Langer AJ, Cowan LS, Starks AM, LoBue PA
المصدر: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2024 Jan 05; Vol. 72 (5253), pp. 1385-1389. Date of Electronic Publication: 2024 Jan 05.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Electronic Cited Medium: Internet ISSN: 1545-861X (Electronic) Linking ISSN: 01492195 NLM ISO Abbreviation: MMWR Morb Mortal Wkly Rep Subsets: MEDLINE
مواضيع طبية MeSH: Tuberculosis*/epidemiology , Tuberculosis*/diagnosis , Mycobacterium tuberculosis*/genetics, Humans ; United States/epidemiology ; Tissue Donors ; Disease Outbreaks ; Allografts
-
3دورية أكاديمية
المؤلفون: Feng PI; Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30329, USA., Horne DJ; University of Washington School of Medicine and Public Health-Seattle and King County, 3980 15 Avenue NE, Box 351616, Seattle, WA 98195-1616, USA., Wortham JM; Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30329, USA., Katz DJ; Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30329, USA.
مؤلفون مشاركون: CDC Tuberculosis Epidemiologic Studies Consortium
المصدر: Journal of clinical tuberculosis and other mycobacterial diseases [J Clin Tuberc Other Mycobact Dis] 2023 Jun 13; Vol. 33, pp. 100382. Date of Electronic Publication: 2023 Jun 13 (Print Publication: 2023).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101682877 Publication Model: eCollection Cited Medium: Internet ISSN: 2405-5794 (Electronic) Linking ISSN: 24055794 NLM ISO Abbreviation: J Clin Tuberc Other Mycobact Dis Subsets: PubMed not MEDLINE
-
4دورية أكاديمية
المؤلفون: Ortega-Villa AM; Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA., Hynes NA; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Levine CB; Division of Infectious Disease, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA., Yang K; Department of Clinical Pharmacy, University of California, San Francisco, San Francisco, California, USA., Wiley Z; Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA., Jilg N; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Wang J; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA., Whitaker JA; Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA., Colombo CJ; Department of Virtual Health and Department of Medicine, Madigan Army Medical Center, Tacoma, Washington, USA.; Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA., Nayak SU; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Kim HJ; Department of Community Health Systems, School of Nursing, University of California, San Francisco, San Francisco, California, USA.; National Patient Care Services, Kaiser Permanente, Oakland, California, USA., Iovine NM; Division of Infectious Diseases and Global Medicine, Department of Medicine, University of Florida Health, Gainesville, Florida, USA., Ince D; Division of Infectious Diseases, Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA., Cohen SH; Division of Infectious Diseases, University of California, Davis, Sacramento, California, USA., Langer AJ; COVID-19 Emergency Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Wortham JM; COVID-19-Associated Hospitalization Surveillance Network, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Atmar RL; Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., El Sahly HM; Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA., Jain MK; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Mehta AK; Division of Infection Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.; National Emerging Special Pathogens Treatment and Education Center, Atlanta, Georgia, USA., Wolfe CR; Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Gomez CA; Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA., Beresnev T; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Mularski RA; Department of Pulmonary and Critical Care Medicine, Northwest Permanente, Kaiser Permanente Northwest, Portland, Oregon, USA.; The Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA., Paules CI; Division of Infectious Diseases, Penn State Health Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA., Kalil AC; Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA., Branche AR; Division of Infectious Diseases, Department of Medicine, University of Rochester Medical Center, Rochester, New York, USA., Luetkemeyer A; Department of Medicine, University of California, San Francisco, San Francisco, California, USA., Zingman BS; Department of Medicine, Montefiore Medical Center, University Hospital for Albert Einstein College of Medicine, Bronx, New York, USA., Voell J; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Whitaker M; COVID-19-Associated Hospitalization Surveillance Network, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Harkins MS; Division of Pulmonary and Critical Care, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, USA., Davey RT Jr; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Grossberg R; Division of Infectious Diseases, Department of Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, USA., George SL; Department of Internal Medicine, Saint Louis University and St Louis Veterans Affairs Medical Center, St Louis, Missouri, USA., Tapson V; Division of Pulmonary and Critical Care, Cedars-Sinai Medical Center, Los Angeles, California, USA., Short WR; Division of Infectious Diseases, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Ghazaryan V; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Benson CA; Division of Infectious Diseases and Global Public Health, University of California, San Diego, San Diego, California, USA., Dodd LE; Biostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA., Sweeney DA; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of California, San Diego, San Diego, California, USA., Tomashek KM; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
المصدر: Open forum infectious diseases [Open Forum Infect Dis] 2023 May 27; Vol. 10 (6), pp. ofad290. Date of Electronic Publication: 2023 May 27 (Print Publication: 2023).
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE
-
5دورية أكاديمية
المؤلفون: Li R; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Deutsch-Feldman M; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Adams T; Infection Prevention Department, Lutheran Health Network, Fort Wayne, Indiana, USA., Law M; Risk Management Department, Lutheran Health Network, Fort Wayne, Indiana, USA., Biak C; Infectious Disease Epidemiology and Prevention Division, Indiana Department of Health, Indianapolis, Indiana, USA., Pitcher E; Clinical Services Department, Allen County Department of Health, Fort Wayne, Indiana, USA., Drees M; Quality and Safety Administration, ChristianaCare, Wilmington, Delaware, USA., Hernandez-Romieu AC; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Filardo TD; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Cropper T; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Martinez A; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Wyatt Wilson W; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Althomsons SP; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Morris SB; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Wortham JM; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Benowitz I; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Schwartz NG; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., White K; Infectious Disease Epidemiology and Prevention Division, Indiana Department of Health, Indianapolis, Indiana, USA., Haddad MB; Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Glowicz JB; Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
مؤلفون مشاركون: Bone Allograft Tuberculosis Investigators
المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2023 May 24; Vol. 76 (10), pp. 1847-1849.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
مواضيع طبية MeSH: Mycobacterium tuberculosis* , Tuberculosis*/epidemiology, Humans ; United States/epidemiology ; Disease Outbreaks ; Health Personnel ; Delivery of Health Care
-
6دورية أكاديمية
المؤلفون: Woodruff RC; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Electronic address: okp9@cdc.gov., Garg S; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; United States Public Health Service Commissioned Corps, Rockville, Maryland, USA., George MG; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Patel K; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; General Dynamics Information Technology, Atlanta, Georgia, USA., Jackson SL; Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Loustalot F; Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA; United States Public Health Service Commissioned Corps, Rockville, Maryland, USA., Wortham JM; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; United States Public Health Service Commissioned Corps, Rockville, Maryland, USA., Taylor CA; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Whitaker M; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Reingold A; University of California, Berkeley, California, USA; California Emerging Infections Program, Oakland, California, USA., Alden NB; Colorado Department of Public Health and Environment, Denver, Colorado, USA., Meek J; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA., Anderson EJ; Departments of Medicine and Pediatrics, Emory School of Medicine, Atlanta, Georgia, USA; Georgia Emerging Infections Program, Georgia Department of Public Health, Atlanta, Georgia, USA; Atlanta Veterans Affairs Medical Center, Atlanta, Georgia, USA., Weigel A; Iowa Department of Public Health, Des Moines, Iowa, USA., Henderson J; Michigan Department of Health and Human Services, Lansing, Michigan, USA., Bye E; Minnesota Department of Health, St Paul, Minnesota, USA., Davis SS; New Mexico Emerging Infections Program, Albuquerque, New Mexico, USA., Barney G; New York State Department of Health, Albany, New York, USA., Bennett NM; University of Rochester School of Medicine and Dentistry, Rochester, New York, USA., Shiltz E; Ohio Department of Health, Columbus, Ohio, USA., Sutton M; Public Health Division, Oregon Health Authority, Portland, Oregon, USA., Talbot HK; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Price A; Salt Lake County Health Department, Salt Lake City, Utah, USA., Sperling LS; Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Havers FP; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA; United States Public Health Service Commissioned Corps, Rockville, Maryland, USA.
مؤلفون مشاركون: COVID-19-Associated Hospitalization Surveillance Network
المصدر: Journal of the American College of Cardiology [J Am Coll Cardiol] 2023 Feb 14; Vol. 81 (6), pp. 557-569.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
بيانات الدورية: Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE
مواضيع طبية MeSH: COVID-19*/complications , COVID-19*/epidemiology , Heart Diseases*/epidemiology, Adult ; Humans ; SARS-CoV-2 ; Hospital Mortality ; Hospitalization
-
7دورية أكاديمية
المؤلفون: Schwartz NG; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, US Centers for Disease Control and Prevention, Atlanta, GA, USA; Epidemic Intelligence Service, US Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: nschwartz@cdc.gov., Hernandez-Romieu AC; Epidemic Intelligence Service, US Centers for Disease Control and Prevention, Atlanta, GA, USA; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Annambhotla P; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Filardo TD; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, US Centers for Disease Control and Prevention, Atlanta, GA, USA; Epidemic Intelligence Service, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Althomsons SP; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Free RJ; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Li R; Epidemic Intelligence Service, US Centers for Disease Control and Prevention, Atlanta, GA, USA; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Wilson WW; Epidemic Intelligence Service, US Centers for Disease Control and Prevention, Atlanta, GA, USA; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Deutsch-Feldman M; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, US Centers for Disease Control and Prevention, Atlanta, GA, USA; Epidemic Intelligence Service, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Drees M; ChristianaCare, Newark, DE, USA., Hanlin E; Delaware Department of Health and Social Services, Division of Public Health, Dover, DE, USA., White K; Indiana Department of Health, Indianapolis, IN, USA., Lehman KA; National Veterinary Services Laboratories, Veterinary Services, Animal and Plant Health Inspection Service, US Department of Agriculture, Ames, IA, USA., Thacker TC; National Veterinary Services Laboratories, Veterinary Services, Animal and Plant Health Inspection Service, US Department of Agriculture, Ames, IA, USA., Brubaker SA; Division of Human Tissues, Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Clark B; Division of Human Tissues, Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Basavaraju SV; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Benowitz I; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Burton Glowicz J; Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Cowan LS; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Starks AM; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Bamrah Morris S; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, US Centers for Disease Control and Prevention, Atlanta, GA, USA., LoBue P; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Stewart RJ; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Wortham JM; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, US Centers for Disease Control and Prevention, Atlanta, GA, USA., Haddad MB; Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
مؤلفون مشاركون: Bone Allograft Tuberculosis Investigators
المصدر: The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Nov; Vol. 22 (11), pp. 1617-1625. Date of Electronic Publication: 2022 Aug 04.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE
مواضيع طبية MeSH: Tuberculosis*/epidemiology , Organ Transplantation*/adverse effects , Mycobacterium tuberculosis*/genetics, Male ; Humans ; United States/epidemiology ; Phylogeny ; Tissue Donors ; Disease Outbreaks
-
8دورية أكاديمية
المؤلفون: Raz KM; Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: ynp6@cdc.gov., Talarico S; Centers for Disease Control and Prevention, Atlanta, GA, USA., Althomsons SP; Centers for Disease Control and Prevention, Atlanta, GA, USA., Kammerer JS; Centers for Disease Control and Prevention, Atlanta, GA, USA., Cowan LS; Centers for Disease Control and Prevention, Atlanta, GA, USA., Haddad MB; Centers for Disease Control and Prevention, Atlanta, GA, USA., McDaniel CJ; Centers for Disease Control and Prevention, Atlanta, GA, USA., Wortham JM; Centers for Disease Control and Prevention, Atlanta, GA, USA., France AM; Centers for Disease Control and Prevention, Atlanta, GA, USA., Powell KM; Centers for Disease Control and Prevention, Atlanta, GA, USA., Posey JE; Centers for Disease Control and Prevention, Atlanta, GA, USA., Silk BJ; Centers for Disease Control and Prevention, Atlanta, GA, USA.
المصدر: Tuberculosis (Edinburgh, Scotland) [Tuberculosis (Edinb)] 2022 Sep; Vol. 136, pp. 102232. Date of Electronic Publication: 2022 Aug 09.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 100971555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-281X (Electronic) Linking ISSN: 14729792 NLM ISO Abbreviation: Tuberculosis (Edinb) Subsets: MEDLINE
مواضيع طبية MeSH: Ill-Housed Persons* , Mycobacterium tuberculosis*/genetics , Tuberculosis*/diagnosis , Tuberculosis*/epidemiology, Disease Outbreaks ; Genotype ; Humans ; United States/epidemiology
-
9دورية أكاديمية
المؤلفون: Stewart RJ; The authors are with the Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA., Raz KM; The authors are with the Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA., Burns SP; The authors are with the Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA., Kammerer JS; The authors are with the Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA., Haddad MB; The authors are with the Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA., Silk BJ; The authors are with the Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA., Wortham JM; The authors are with the Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
المصدر: American journal of public health [Am J Public Health] 2022 Aug; Vol. 112 (8), pp. 1170-1179.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Public Health Association Country of Publication: United States NLM ID: 1254074 Publication Model: Print Cited Medium: Internet ISSN: 1541-0048 (Electronic) Linking ISSN: 00900036 NLM ISO Abbreviation: Am J Public Health Subsets: MEDLINE
مواضيع طبية MeSH: Prisoners* , Tuberculosis*/epidemiology, Disease Outbreaks ; Genotype ; Humans ; Prisons ; Texas ; United States/epidemiology
-
10دورية أكاديمية
المؤلفون: Labuda SM; Arkansas Department of Health, Little Rock, AR, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA., McDaniel CJ; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA., Talwar A; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA.; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA., Braumuller A; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA., Parker S; Arkansas Department of Health, Little Rock, AR, USA., McGaha S; Arkansas Department of Health, Little Rock, AR, USA., Blissett C; Arkansas Department of Health, Little Rock, AR, USA., Wortham JM; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA., Mukasa L; Arkansas Department of Health, Little Rock, AR, USA., Stewart RJ; Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
المصدر: Public health reports (Washington, D.C. : 1974) [Public Health Rep] 2022 Jan-Feb; Vol. 137 (1), pp. 94-101. Date of Electronic Publication: 2021 Mar 17.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
بيانات الدورية: Publisher: SAGE Publications Country of Publication: United States NLM ID: 9716844 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2877 (Electronic) Linking ISSN: 00333549 NLM ISO Abbreviation: Public Health Rep Subsets: MEDLINE
مواضيع طبية MeSH: Rural Population*, Delayed Diagnosis/*statistics & numerical data , Tuberculosis/*ethnology, Adolescent ; Adult ; Black or African American ; Alcoholism/epidemiology ; Arkansas/epidemiology ; Child ; Comorbidity ; Disease Outbreaks ; Female ; Genotype ; Humans ; Male ; Mycobacterium tuberculosis/genetics ; Polymorphism, Single Nucleotide ; Tuberculosis/diagnosis ; Young Adult